AI creates novel medications by learning from 1 mil species

Basecamp Research, a UK business, unveiled Eden, a new family of AI models created in collaboration with Nvidia that used evolutionary data from 1 million species to potentially create novel cures for drug-resistant infections and genetic illnesses.

The specifics:

Eden studied how animals developed over billions of years to handle biological challenges using DNA taken from 28 different countries.

A potentially safer way than CRISPR, the AI created a new kind of gene-editing tool that can introduce therapeutic DNA without cutting it.

More than 63% of the AI-designed medicines worked in lab testing for conditions including hemophilia and muscular dystrophy.

Additionally, 97% of the novel antibiotic candidates that Eden developed were successful in combating deadly "superbugs" that are resistant to current medications.

Until they require a medication that doesn't already exist, most individuals don't consider where new medications originate from. Treatments for hereditary illnesses and the rising problem of antibiotic-resistant infections that existing medications are unable to treat might be accelerated by Basecamp's method of training AI to learn from billions of years of evolution.

AI creates novel medications by learning from 1 million species